EP1718965 - CCN1 TRANSGENIC ANIMALS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.01.2012 Database last updated on 24.08.2024 | Most recent event Tooltip | 27.01.2012 | Application deemed to be withdrawn | published on 29.02.2012 [2012/09] | Applicant(s) | For all designated states Munin Corporation P.O. Box 3067 Oak Park, IL 60303-3067 / US | [2006/45] | Inventor(s) | 01 /
LAU, Lester, F. 2677 N. Ochard Street Chicago, IL 60614 / US | [2006/45] | Representative(s) | den Hartog, Jeroen H.J., et al Hoyng Rokh Monegier LLP Rembrandt Tower, 31st Floor Amstelplein 1 1096 HA Amsterdam / NL | [N/P] |
Former [2011/51] | den Hartog, Jeroen H.J., et al Hoyng Monegier LLP Rembrandt Tower, 31st Floor Amstelplein 1 1096 HA Amsterdam / NL | ||
Former [2008/34] | Rasser, Jacobus Cornelis, et al Howrey LLP Rembrandt Tower, 31st Floor Amstelplein 1 1096 HA Amsterdam / NL | ||
Former [2006/45] | Rasser, Jacobus Cornelis, et al Howrey LLP Rembrandt Tower Amstelplein 1, 31st Floor 1096 HA Amsterdam / NL | Application number, filing date | 05722953.6 | 09.02.2005 | [2006/45] | WO2005US04354 | Priority number, date | US20040774706 | 09.02.2004 Original published format: US 774706 | [2006/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005077095 | Date: | 25.08.2005 | Language: | EN | [2005/34] | Type: | A2 Application without search report | No.: | EP1718965 | Date: | 08.11.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.08.2005 takes the place of the publication of the European patent application. | [2006/45] | Search report(s) | International search report - published on: | US | 16.02.2006 | (Supplementary) European search report - dispatched on: | EP | 21.09.2009 | Classification | IPC: | G01N33/00, A01K67/00 | [2006/45] | CPC: |
A01K67/0275 (EP,US);
A01K67/0276 (EP,US);
C07K14/4743 (EP,US);
C12N15/8509 (EP,US);
A01K2217/072 (EP,US);
A01K2217/075 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/45] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | CCN1-TRANSGENE TIERE | [2006/45] | English: | CCN1 TRANSGENIC ANIMALS | [2006/45] | French: | ANIMAUX TRANSGENIQUES CCN1 | [2006/45] | Entry into regional phase | 01.09.2006 | National basic fee paid | 01.09.2006 | Search fee paid | 01.09.2006 | Designation fee(s) paid | 01.09.2006 | Examination fee paid | Examination procedure | 01.09.2006 | Examination requested [2006/45] | 16.06.2010 | Despatch of a communication from the examining division (Time limit: M04) | 26.10.2010 | Reply to a communication from the examining division | 28.04.2011 | Despatch of a communication from the examining division (Time limit: M02) | 28.06.2011 | Reply to a communication from the examining division | 01.09.2011 | Application deemed to be withdrawn, date of legal effect [2012/09] | 10.10.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/09] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.06.2010 | Fees paid | Renewal fee | 01.09.2006 | Renewal fee patent year 03 | 08.02.2008 | Renewal fee patent year 04 | 27.08.2009 | Renewal fee patent year 05 | 22.06.2010 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 28.02.2009 | 05   M06   Fee paid on   27.08.2009 | 28.02.2010 | 06   M06   Fee paid on   22.06.2010 | 28.02.2011 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0155210 (MUNIN CORP [US], et al) [A] 1 * page 11, line 15 - line 23; claims 18-24 * * page 38, line 13 - line 16; example 4 * * page 40, line 21 - line 23; example 5 *; | [PX] - LEU SJ, CHEN N, CHEN CC, TODOROVIC V, BAI T, JURIC V, LIU Y, YAN G, LAM SC, LAU LF, "Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions", J BIOL CHEM., (20040817), vol. 279, no. 42, pages 44177 - 44187, XP002545076 [PX] 1-21 * the whole document * DOI: http://dx.doi.org/10.1074/JBC.M407850200 | [T] - MO FE, LAU LF., "The matricellular protein CCN1 is essential for cardiac development.", CIRC RES., (20061005), vol. 99, no. 9, pages 961 - 969, XP002545077 [T] 1 * the whole document * DOI: http://dx.doi.org/10.1161/01.RES.0000248426.35019.89 | International search | [X] - MO F.-E. ET AL, MOLECULAR AND CELLULAR BIOLOGY, (2002), vol. 22, pages 8709 - 8720, XP002994842 DOI: http://dx.doi.org/10.1128/MCB.22.24.8709-8720.2002 | by applicant | - MO. F- E. ET AL., "CYR61 (CCN1) is Essential for Placental Development and Vascular Integrity", MOLECULAR AND CELLULAR BIOLOGY, (2002), vol. 22, pages 8709 - 8720 |